The NFL and NFLPA already have agreed to conduct a population study aimed at determining the baseline levels of HGH in pro football players. On Wednesday, a broader agreement could be struck.
According to Albert Breer of NFL Network, the league and union will meet Wednesday in D.C., with the goal of striking a comprehensive HGH testing plan. Per Breer, the meeting is deemed to be “critical” to the effort.
As we explained Monday, issues include the use of third-party arbitration to challenge positive tests, the confidentiality of test results, and the procedures for disposing of samples after testing. The league, we’re told, is interested in retroactive testing of the samples that will be used for the population study. Per one source with knowledge of the NFLPA’s position, the players never will agree to that.
Without the threat of retroactive testing, players who are using HGH have a clear incentive to keep using it, in order to skew the population study higher.
So, basically, inject ’em if you got ’em. Before too long, the HGH honor system will evaporate.